CabaCy—evaluating Cabazitaxel efficaCy by patterns of treatment and disease in metastatic castration resistant prostate cancer (mCRPC) patients: a 5 years, “Real Life”, mono-institutional experience
Titel:
CabaCy—evaluating Cabazitaxel efficaCy by patterns of treatment and disease in metastatic castration resistant prostate cancer (mCRPC) patients: a 5 years, “Real Life”, mono-institutional experience
Auteur:
Rossetti, S. Cavaliere, C. Romano, F.J. Di Napoli, M. Cecere, S.C. Iovane, G. Porricelli, M.A. Pignata, S. Facchini, G.